These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26865352)
21. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas. Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069 [TBL] [Abstract][Full Text] [Related]
22. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Bauer S; Hartmann JT; de Wit M; Lang H; Grabellus F; Antoch G; Niebel W; Erhard J; Ebeling P; Zeth M; Taeger G; Seeber S; Flasshove M; Schütte J Int J Cancer; 2005 Nov; 117(2):316-25. PubMed ID: 15900603 [TBL] [Abstract][Full Text] [Related]
23. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor. Alturkmani HJ; Pessetto ZY; Godwin AK Expert Opin Investig Drugs; 2015; 24(8):1045-58. PubMed ID: 26098203 [TBL] [Abstract][Full Text] [Related]
24. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy. Namikawa T; Munekage E; Munekage M; Maeda M; Yatabe T; Kitagawa H; Sakamoto K; Obatake M; Kobayashi M; Hanazaki K Anticancer Res; 2016 Apr; 36(4):1855-9. PubMed ID: 27069170 [TBL] [Abstract][Full Text] [Related]
25. Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib. Yilmaz H; Demirağ G; Yılmaz A J Pharm Pharm Sci; 2021; 24():148-152. PubMed ID: 33784493 [TBL] [Abstract][Full Text] [Related]
26. Current management of gastrointestinal stromal tumors--a comprehensive review. Lai EC; Lau SH; Lau WY Int J Surg; 2012; 10(7):334-40. PubMed ID: 22633986 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate]. Haugland HK; Jebsen NL; Mannelqvist M; Skar R; Eide J; Øvrebø K; Horn A; Jensen DK; Monge OR; Lilleng PK Tidsskr Nor Laegeforen; 2005 Apr; 125(7):868-72. PubMed ID: 15815732 [TBL] [Abstract][Full Text] [Related]
28. [Medical therapy of GIST; from palliative to curative treatment]. Le Cesne A; Blay JY Bull Acad Natl Med; 2012; 196(4-5):861-74; discussion 874-76. PubMed ID: 23550449 [TBL] [Abstract][Full Text] [Related]
29. The role of KIT in the management of patients with gastrointestinal stromal tumors. Hornick JL; Fletcher CD Hum Pathol; 2007 May; 38(5):679-87. PubMed ID: 17437861 [TBL] [Abstract][Full Text] [Related]
30. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Janeway KA; Albritton KH; Van Den Abbeele AD; D'Amato GZ; Pedrazzoli P; Siena S; Picus J; Butrynski JE; Schlemmer M; Heinrich MC; Demetri GD Pediatr Blood Cancer; 2009 Jul; 52(7):767-71. PubMed ID: 19326424 [TBL] [Abstract][Full Text] [Related]
31. Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications. Park SR; Ryu MH; Ryoo BY; Beck MY; Lee IS; Choi MJ; Lee MW; Kang YK Cancer Res Treat; 2016 Jan; 48(1):162-70. PubMed ID: 26323636 [TBL] [Abstract][Full Text] [Related]
32. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. Eisenberg BL; Harris J; Blanke CD; Demetri GD; Heinrich MC; Watson JC; Hoffman JP; Okuno S; Kane JM; von Mehren M J Surg Oncol; 2009 Jan; 99(1):42-7. PubMed ID: 18942073 [TBL] [Abstract][Full Text] [Related]
33. New strategies for treating GIST when imatinib fails. Boyar MS; Taub RN Cancer Invest; 2007 Aug; 25(5):328-35. PubMed ID: 17661208 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors. Cohen NA; Zeng S; Seifert AM; Kim TS; Sorenson EC; Greer JB; Beckman MJ; Santamaria-Barria JA; Crawley MH; Green BL; Rossi F; Besmer P; Antonescu CR; DeMatteo RP Cancer Res; 2015 May; 75(10):2061-70. PubMed ID: 25836719 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors. Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T Digestion; 2013; 87(1):47-52. PubMed ID: 23343969 [TBL] [Abstract][Full Text] [Related]
36. Role of surgery in patients with recurrent, metastatic, or unresectable locally advanced gastrointestinal stromal tumors sensitive to imatinib: a retrospective analysis of the Spanish Group for Research on Sarcoma (GEIS). Rubió-Casadevall J; Martinez-Trufero J; Garcia-Albeniz X; Calabuig S; Lopez-Pousa A; Del Muro JG; Fra J; Redondo A; Lainez N; Poveda A; Valverde C; De Juan A; Sevilla I; Casado A; Andres R; Cruz J; Martin-Broto J; Maurel J; Ann Surg Oncol; 2015 Sep; 22(9):2948-57. PubMed ID: 25608769 [TBL] [Abstract][Full Text] [Related]
37. Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment. Sleijfer S; Wiemer E; Seynaeve C; Verweij J Oncologist; 2007 Jun; 12(6):719-26. PubMed ID: 17602061 [TBL] [Abstract][Full Text] [Related]
38. [Research advance of liquid biopsy in gastrointestinal stromal tumors]. Sun JY; Gao XD; Shen KT Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):917-921. PubMed ID: 32927519 [TBL] [Abstract][Full Text] [Related]
39. [Medical treatment for gastrointestinal stromal tumor (GIST) in Japan]. Sato A; Hamada K; Imataka H Gan To Kagaku Ryoho; 2012 May; 39(5):708-12. PubMed ID: 22584320 [TBL] [Abstract][Full Text] [Related]
40. The outcome of targeted therapy in advanced gastrointestinal stromal tumors (GIST) with non-exon 11 KIT mutations. Osuch C; Rutkowski P; Brzuszkiewicz K; Bylina E; Limon J; Siedlecki JA Pol Przegl Chir; 2014 Jul; 86(7):325-32. PubMed ID: 25222580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]